worthless now, page-21

People seem surprised that MBP has had two flops. I don't know why they should be. There are statistics published in medical journals about the average ultimate success rates of drugs in Phase IIA, Phase I etc trials and let me tell you they are no where near 50:50. No spin, no BS or hype, just raw numbers. I've seen a powerpoint presentations with the numbers on the web somewhere but I can't seem to find it anymore. Let me tell you anyone who says we're about to see a biotech boom is dreaming. Unless the medical journal was publishing bogus figures. The startup biotech sector is right up there with junior resource explorers in both eventual chance of commerciality and rate of shareholder wealth destruction.